stevenpaul, Author at European Medical Journal - Page 18 of 37

The Emerging Role of Homologous Recombination Deficiency Testing and the Progress of PARP Inhibitors in Advanced Ovarian Cancer: Interviews with Three Key Opinion Leaders

Ovarian cancer is the most lethal gynaecologic malignancy worldwide because of its vague presentation, insidious nature, recurrence, and drug resistance.

From Clinical Trial to Real-World Evidence: Everyday Practice with METex14 Inhibitors in NSCLC

This recent hybrid satellite symposium, presented at the European Society for Medical Oncology (ESMO) 2022 Congress, addressed the current clinical practice for the management of patients with METexon14 (METex14) non-small cell lung cancer (NSCLC).

Retracted: Building on a Strong Foundation to Address a New Era to Help Protect Against Pneumococcal Disease

Ramirez noted that more than 100 pneumococcal serotypes have now been identified, which is most likely the result of increased…

Cutaneous Mucormycosis Co-infection in a Patient with COVID-19

A 54-year-old male tested positive in late February on a screening COVID-19 test performed after a family member’s test had become positive. A few weeks later, they presented to the emergency room at a different hospital centre with shortness of breath and fever.

Tumour Organoids from Multifocal Metastatic Colorectal Cancers for Personalised Oncology

Patients with colorectal cancer (CRC) have limited systemic treatment options compared to other major cancer types.1 Tumour heterogeneity is a major cause of treatment failure.

Does Hepatitis C Independently Increase the Risk of Colorectal Adenoma?

Hepatitis C virus (HCV) infection has been associated with extrahepatic malignancies such as colorectal carcinoma (CRC). The majority of CRCs arise from adenomatous polyps, and it is not known if HCV infection influences the growth of these pre-cancerous lesions.

CT Colonography Versus Optical Colonoscopy: Cost-Effectiveness in Colorectal Cancer Screening

In 2017, colorectal cancer (CRC) accounted for 13% of new malignancy diagnoses in Canada. It is the second leading cause of cancer-related deaths in Canadian males, and the third leading cause of cancer related deaths in Canadian females.

An Unexpected Post-ocrelizumab Improvement in Glycaemic Control in a Patient with Multiple Sclerosis

Multiple sclerosis (MS) is a chronic inflammatory autoimmune disease of the central nervous system, causing a plethora of neurological manifestations and a leading cause of non-traumatic disability among young adults.

Current challenges and future perspectives in Juvenile Psoriatic Arthritis and Enthesitis Related Arthritis

As part of Novartis’ continued commitment to medical education in rheumatology. We Invite you to our faculty as they discuss: -The disease state of JPsA and ERA and the impact of diagnosis, clinical features, and disease activity on patients and caregivers. -The importance of both the patient perspective and the unmet needs for optimizing the management of JPsA and ERA -Clinical evidence for IL17 inhibition in the management of ERA and JPsA.

An Observational Study on Unique High Resolution Computed Tomography Pattern of Post-COVID Pulmonary Fibrosis

The parenchyma of the lungs can undergo fibrosis due to known aetiology such as radiation or drug induced fibrosis; occupational or connective tissue related interstitial lung disease; or it may have genetic basis or remain idiopathic, as in idiopathic pulmonary fibrosis.